USE OF A P38 KINASE INHIBITOR FOR TREATING PSYCHIATRIC DISORDERS
摘要
<p>The use of 6- (S-Cyclopropylcarbamoyl-S-fluoro-2-methyl -phenyl) -N- (2, 2-dimethylproyl) - nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.</p>
